Cargando…

Disabling an oncogenic transcription factor by targeting of control kinases

Detalles Bibliográficos
Autores principales:	Vakoc, Christopher R., Kentsis, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122356/ https://www.ncbi.nlm.nih.gov/pubmed/30190784 http://dx.doi.org/10.18632/oncotarget.25971

Ejemplares similares

Oncogene interference through targeting of chromatin regulators
por: Roe, Jae-Seok, et al.
Publicado: (2013)

Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia
por: Takao, Sumiko, et al.
Publicado: (2021)

Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015)

Targeting of non-oncogene addiction
por: Igea, Ana, et al.
Publicado: (2015)

Targeting the Vulnerabilities of Oncogene Activation
por: Huang, Christina, et al.
Publicado: (2023)

The oncogenic transcription factor FOXM1 and anticancer therapy
por: Gartel, Andrei L.
Publicado: (2012)

Targeting DUBs to degrade oncogenic proteins
por: Cremer, Anjali, et al.
Publicado: (2020)

Targeting the Oncogenic TBX2 Transcription Factor With Chromomycins
por: Sahm, Bianca Del B., et al.
Publicado: (2020)

Regulation of oncogenic PI3-kinase signaling by JARID1B
por: Facompre, Nicole D., et al.
Publicado: (2017)

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
por: Stolzenburg, Sabine, et al.
Publicado: (2012)

Oncogenic Processes
por: Stocco, Rita de Cassia, et al.
Publicado: (2014)

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
por: Brien, Gerard L, et al.
Publicado: (2018)

IRF4 as an Oncogenic Master Transcription Factor
por: Wong, Regina Wan Ju, et al.
Publicado: (2022)

Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy
por: Qi, Xiao-Mei, et al.
Publicado: (2018)

Recent Advances in Carcinogenesis Transcription Factors: Biomarkers and Targeted Therapies
por: Bode, Ann M., et al.
Publicado: (2023)

Widening the concept of oncogene
por: Casas-Tintó, Sergio, et al.
Publicado: (2016)

Evidence of pioneer factor activity of an oncogenic fusion transcription factor
por: Sunkel, Benjamin D., et al.
Publicado: (2021)

Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities
por: Dricu, Anica
Publicado: (2022)

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
por: Crosby, Erika J., et al.
Publicado: (2021)

Ageing and Disability According to the Perspective of Clinical Psychology of Disability
por: Petretto, Donatella R., et al.
Publicado: (2022)

Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
por: Oran, Amanda R., et al.
Publicado: (2016)

Oncogenic drivers and mitochondrial dependency
por: Alvarez-Calderon, Francesca, et al.
Publicado: (2015)

Rab1 GTPases as oncogenes
por: Li, Yue, et al.
Publicado: (2015)

Advances in Molecular Research of Oncogenes
por: Baltanas, Fernando C., et al.
Publicado: (2023)

The Oncogenic Functions of MASTL Kinase
por: Marzec, Kamila, et al.
Publicado: (2018)

The potential of glioma-associated oncogene homolog 1 (GLI1) as a therapeutic target in endometriosis
por: Nirgianakis, Konstantinos, et al.
Publicado: (2020)

The Oncogene Transcription Factor EB Regulates Vascular Functions
por: Doronzo, Gabriella, et al.
Publicado: (2021)

Covalent Degrader of the Oncogenic Transcription Factor β-Catenin
por: Gowans, Flor A., et al.
Publicado: (2023)

An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets
por: Zeller, Karen I, et al.
Publicado: (2003)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

An oncogenic role for sphingosine kinase 2
por: Neubauer, Heidi A., et al.
Publicado: (2016)

Role of transcription-regulating kinase CDK8 in colon cancer metastasis
por: Liang, Jiaxin, et al.
Publicado: (2019)

Oncogene alterations in non-small cell lung cancer—have we MET a new target?
por: Dempke, Wolfram C. M., et al.
Publicado: (2022)

Oncogene addiction: resetting the safety switch?
por: Li, Yulin, et al.
Publicado: (2014)

Oncogene-induced NAD(+) depletion in tumorigenesis
por: Tummala, Krishna S., et al.
Publicado: (2015)

BIM-mediated apoptosis and oncogene addiction
por: Li, Yulin, et al.
Publicado: (2016)

Disability unplugged: What really matters to people with disabilities?
por: Ohajunwa, Chioma, et al.
Publicado: (2022)

Targeting the protein kinases for anti-cancer therapy
por: Bang, Soo-Mee
Publicado: (2012)

Targeting LIM kinases in taxane resistant tumors
por: Prunier, Chloé, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mh1hqb05dv8uqtrocpigq84k4u